A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer

Clinical trial NCT04137289 · COMPLETED

Trial details

NCT number: NCT04137289
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Neoplasms Cholangiocarcinoma Pancreatic Neoplasms

Start date: 2020-03-11
Primary completion: 2023-07-26
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.